# EDGAR Filing Document

**Accession Number:** 0001798480
**File Stem:** 0001127602-25-019238
**Filing Date:** 2025-7
**Character Count:** 10859
**Document Hash:** c33b8a7fdd415e2e903004295eea5a81
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-25-019238.hdr.sgml**: 20250716

**ACCESSION NUMBER**: 0001127602-25-019238

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250715

**FILED AS OF DATE**: 20250716

**DATE AS OF CHANGE**: 20250716

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Williams Terrance
- **CENTRAL INDEX KEY:** 0001798480

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10315
- **FILM NUMBER:** 251126921

**MAIL ADDRESS:**
- **STREET 1:** 7184 BIDDICK
- **CITY:** NEW ALBANY
- **STATE:** OH
- **ZIP:** 43054
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Encompass Health Corp
- **CENTRAL INDEX KEY:** 0000785161
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOSPITALS [8060]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 630860407
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9001 LIBERTY PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35242
- **BUSINESS PHONE:** 205-967-7116

**MAIL ADDRESS:**
- **STREET 1:** 9001 LIBERTY PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35242

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHSOUTH CORP
- **DATE OF NAME CHANGE:** 19950113

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHSOUTH REHABILITATION CORP
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS THAT the undersigned hereby
 constitutes and appoints Patrick Darby and Stephen Leasure, and each of
them individually, the undersigned?s true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the capacity as an
officer and/or director of Encompass Health Corporation, a Delaware
corporation (the ?Company?), Forms 3, 4 and 5, Schedule 13D and
 Schedule 13G and amendments thereto in accordance with
Sections 13(d) and 16(a) of the Securities Exchange Act of 1934 and
 the rules thereunder, and any other forms or reports the undersigned
may be required  to file in connection with the undersigned?s ownership,
acquisition, or disposition  of securities of the Company;

(2) do and perform any and all acts for and on behalf of the undersigned
 Which  may be necessary or desirable to complete the execution of any
such Form 3, 4 or 5, Schedule 13D, Schedule 13G, or other form or report,
and timely file or cause to be filed such form, schedule or report with the
 United States  Securities and Exchange Commission (the ?SEC?) and
 any other authority; and

(3) take any other action of any type whatsoever in connection with
 the foregoing  which, in the opinion of each such attorney-in-fact,
may be of benefit to, in the  best interest of, or legally required by,
the undersigned, it being understood that the documents executed by
such attorney-in-fact on behalf of the undersigned  pursuant to
this Power of Attorney shall be in such form and shall contain such
 terms and conditions as such attorney-in-fact may approve in his
or her discretion.

The undersigned hereby constitutes and appoints Stephen Leasure
and Philip Calagaz, and each of them individually, the undersigned?s
true and lawful attorney-in-fact to:

(1) enroll and register the undersigned as a filer in the SEC?s EDGAR
 system, including the completion And submission of Form ID with
the SEC on behalf of the undersigned; and

(2) act as an account administrator for the undersigned?s EDGAR
account, with all the powers and authority of an account administrator
as described in Rule 10 of Part 232 of Title?17 of the U.S. Code of Federal
Regulations (17 CFR 232.10) and in that certain Final Rule adopted by
the SEC entitled ?EDGAR Filer Access and Account Management?
(SEC Release Nos. 33-11313; 34-101209; 39-2557; IC-35343; File No. S7-15-23)
(Dec. 27, 2024)), and to manage such account, including managing
permissions of other account administrators, users, delegated entities,
and technical administrators who have account credentials to make
submissions on behalf of the undersigned, or to take other action with
respect to the undersigned?s EDGAR account, and ensuring all such
persons comply with EDGAR security protocols.

The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform all and every act and thing whatsoever
requisite, necessary and proper to be done in the exercise of any
of the rights and powers herein granted, as applicable, including assisting
in establishing an account in the name of the undersigned with login.gov,
as to fully satisfy all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
and hereby ratifies and confirms all that such attorney-in-fact, or his or her
substitute or substitutes, shall lawfully do or cause to be done by virtue of
this Power of Attorney and the respective rights and powers herein granted.
The undersigned acknowledges that each foregoing attorney-in-fact, in
erving in his or her above-described capacity or capacities at the request
 of the undersigned, is not assuming any of the undersigned?s responsibilities
to comply with Sections 13(d) and 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5, Schedule 13D,
Schedule 13G,or other form or report with respect to the undersigned?s
holdings of and transactions in securities issued by the Company, unless
revoked by the undersigned in a signed writing delivered to each
foregoing attorney-in fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed effectively as of this 13 day of May 2025.

/s/ Terrance Williams

[Notary Seal]

4906-6207-6731, v. 2

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Williams Terrance<br><sub>(Last) (First) (Middle)</sub><br>9001 LIBERTY PARKWAY<br><sub>(Street)</sub><br>BIRMINGHAM, AL 35242<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-07-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Encompass Health Corp [ EHC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Encompass Health Common Stock | 2025-07-15 |  | A |  | 24<sup>(1)</sup> | A | $0 | 15118 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $107.28. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

**Signature:** /s/ Patrick Darby, attorney-in-fact for Terrance Williams  
**Date:** 2025-07-16

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**